Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
Open Access
- 16 April 2018
- journal article
- research article
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 86 (2) , 15
Abstract
In clinical isolates of Mycobacterium tuberculosis (MTB), resistance to pyrazinamide occurs by mutations in any positions of the pncA gene (NC_000962.3) especially in nucleotides 359 and 374. In this study we examined the pncA gene sequence in clinical isolates of MTB. Genomic DNA of 33 clinical isolates of MTB was extracted by the Chelex100 method. The polymerase chain reactions (PCR) were performed using specific primers for amplification of 744 bp amplicon comprising the coding sequences (CDS) of the pncA gene. PCR products were sequenced by an automated sequencing Bioscience system. Additionally, semi Nested-allele specific (sNASP) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methods were carried out for verification of probable mutations in nucleotides 359 and 374. Sequencing results showed that from 33 MTB clinical isolates, nine pyrazinamide-resistant isolates have mutations. Furthermore, no mutation was detected in 24 susceptible strains in the entire 561 bp of the pncA gene. Moreover, new mutations of G→A at position 3 of the pncA gene were identified in some of the resistant isolates. Results showed that the sNASP method could detect mutations in nucleotide 359 and 374 of the pncA gene, but the PCR-RFLP method by the SacII enzyme could not detect these mutations. In conclusion, the identification of new mutations in the pncA gene confirmed the probable occurrence of mutations in any nucleotides of the pncA gene sequence in resistant isolates of MTB.Keywords
This publication has 20 references indexed in Scilit:
- Low rates of synonymous mutations in sequences of Mycobacterium tuberculosis GyrA and KatG genesTuberculosis, 2012
- Prevalence of mutations at codon 463 of katG gene in MDR and XDR clinical isolates of Mycobacterium tuberculosis in Belarus and application of the method in rapid diagnosisActa Microbiologica Et Immunologica Hungarica, 2011
- Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosisTuberculosis, 2009
- Multidrug-Resistant Tuberculosis in Lisbon, Portugal: A Molecular Epidemiological PerspectiveMicrobial Drug Resistance, 2008
- Development and Evaluation of a Line Probe Assay for Rapid Identification of pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis StrainsJournal of Clinical Microbiology, 2007
- pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of BrazilJournal of Antimicrobial Chemotherapy, 2006
- Detection of rpoB Mutations Associated with Rifampin Resistance in Mycobacterium tuberculosis Using Denaturing Gradient Gel ElectrophoresisAntimicrobial Agents and Chemotherapy, 2005
- pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates in PortugalAntimicrobial Agents and Chemotherapy, 2004
- Iron enhances the antituberculous activity of pyrazinamideJournal of Antimicrobial Chemotherapy, 2004
- The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosisNature, 1992